Contents
Quick Summary
- Lemonade (LMND) shares declined approximately 10-12% after releasing Q4 2025 results
- Fourth quarter revenue reached $228.1 million, accompanied by a $0.29 per share net loss
- Annual 2025 revenue totaled $737.9 million, showing year-over-year loss improvement
- Piper Sandler downgraded its price target to $65 from $85, keeping a Neutral stance
- Full-year 2026 outlook anticipates $1.187–$1.192 billion in revenue alongside a $48–$52 million adjusted EBITDA deficit
Shares of Lemonade (LMND) tumbled approximately 10-12% in the trading sessions after the company unveiled its Q4 2025 financial results on February 19, 2026.
The stock retreat occurred despite management delivering what appeared to be the firm’s strongest quarterly performance to date.
Fourth quarter revenue climbed to $228.1 million, representing a 53% increase compared to the same period last year. Net losses contracted to $0.29 per diluted share, while the adjusted EBITDA deficit narrowed to approximately $5 million during the three-month period.
The company’s in-force premium expanded to roughly $1.24 billion, marking another milestone achievement.
For the complete 2025 fiscal year, revenue totaled $737.9 million. Annual net losses came in at $165.5 million, representing an improvement from the previous year’s deficit.
Executives emphasized record-breaking gross profit margins and enhanced cash flow generation as indicators that the business model is reaching maturity.
Analyst Sentiment Shifts
Piper Sandler wasted no time responding to the earnings release, slashing its price objective from $85 down to $65 while maintaining its Neutral stance on the stock.
The investment firm cited Lemonade’s consistent inability to achieve its adjusted EBITDA projections as the primary concern. Despite improvements in underwriting discipline, the insurer continues falling short of its self-imposed profitability milestones.
Piper acknowledged their perspective might be “overly simplistic,” recognizing that Lemonade demonstrates solid execution in the direct-to-consumer personal lines insurance space. Nevertheless, market patience appears to be eroding.
The consensus Wall Street price target currently stands at $65.11, suggesting roughly 14% potential upside from Friday’s closing price of $57.31. Among 11 covering analysts, three maintain Buy ratings or better, five recommend Hold, and three advise Sell.
Forward Guidance Falls Short of Expectations
Looking ahead to 2026, Lemonade projected revenue between $1.187 and $1.192 billion. The top-line growth trajectory remains impressive.
However, the company simultaneously forecasted a full-year adjusted EBITDA loss ranging from $48 to $52 million.
The first quarter of 2026 alone is anticipated to generate an adjusted EBITDA loss of $22 to $25 million.
Management does anticipate achieving positive adjusted EBITDA during Q4 2026, with complete full-year EBITDA profitability now targeted for 2027.
This profitability schedule remains unchanged — which represents a significant portion of the investor disappointment. Market participants had anticipated the company might accelerate its path to profitability.
The disconnect between robust revenue expansion and delayed profit generation explains the current sentiment recalibration.
Artificial Intelligence Advances Move Forward
On a more positive note, Lemonade announced meaningful progress on the technology front. The insurer rolled out an AI-powered autonomous automobile insurance offering during the quarter.
The company’s proprietary AI platform, Blender, now enables claims adjusters to process triple the workload compared to their previous capacity.
Executives indicated that AI implementations are now visible across “pretty much every line” of the organization’s financial statements.
Marketing expenditures have more than tripled, fueled by AI-driven enhancements in pricing algorithms and customer segmentation capabilities.
Longer-term analyst projections estimate revenue approaching $1.8 billion with earnings of $201.4 million by 2028. More optimistic forecasts had previously anticipated revenue reaching $2.0 billion during that timeframe.
Piper Sandler’s revised $65 price target represents 13.4% potential appreciation from the latest closing price of $57.31.
